88 related articles for article (PubMed ID: 3962567)
1. Long-term hormone implant therapy--effects on lipoproteins and steroid levels in post-menopausal women.
Fletcher CD; Farish E; Hart DM; Barlow DH; Gray CE; Conaghan CJ
Acta Endocrinol (Copenh); 1986 Mar; 111(3):419-23. PubMed ID: 3962567
[TBL] [Abstract][Full Text] [Related]
2. The effects of hormone implants on serum lipoproteins and steroid hormones in bilaterally oophorectomised women.
Farish E; Fletcher CD; Hart DM; Azzawi FA; Abdalla HI; Gray CE
Acta Endocrinol (Copenh); 1984 May; 106(1):116-20. PubMed ID: 6730851
[TBL] [Abstract][Full Text] [Related]
3. Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system.
Dobs AS; Bachorik PS; Arver S; Meikle AW; Sanders SW; Caramelli KE; Mazer NA
J Clin Endocrinol Metab; 2001 Mar; 86(3):1026-33. PubMed ID: 11238481
[TBL] [Abstract][Full Text] [Related]
4. Lipoproteins during oral and cutaneous administration of oestradiol-17 beta to menopausal women.
Fåhraeus L; Larsson-Cohn U; Wallentin L
Acta Endocrinol (Copenh); 1982 Dec; 101(4):597-602. PubMed ID: 7158232
[TBL] [Abstract][Full Text] [Related]
5. Long-term post-menopausal hormone therapy and serum HDL-C, total cholesterol and triglycerides.
Vilska S; Punnonen R; Rauramo L
Maturitas; 1983 Aug; 5(2):97-104. PubMed ID: 6415365
[TBL] [Abstract][Full Text] [Related]
6. Lipid and lipoprotein levels following pure estradiol implantation in post-menopausal women.
Sharf M; Oettinger M; Lanir A; Kahana L; Yeshurun D
Gynecol Obstet Invest; 1985; 19(4):207-12. PubMed ID: 4029753
[TBL] [Abstract][Full Text] [Related]
7. Ten years post-menopausal hormone replacement therapy--effect on lipoproteins.
Hart DM; Farish E; Fletcher CD; Howie C; Kitchener H
Maturitas; 1984 Apr; 5(4):271-6. PubMed ID: 6738373
[TBL] [Abstract][Full Text] [Related]
8. The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins, and HDL subfractions in postmenopausal women.
Farish E; Fletcher CD; Hart DM; Teo HT; Alazzawi F; Howie C
Acta Endocrinol (Copenh); 1986 Sep; 113(1):123-7. PubMed ID: 3020851
[TBL] [Abstract][Full Text] [Related]
9. Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens.
Savvas M; Studd JW; Norman S; Leather AT; Garnett TJ; Fogelman I
Br J Obstet Gynaecol; 1992 Sep; 99(9):757-60. PubMed ID: 1420016
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal estrogen and androgen replacement and lipoprotein lipid concentrations.
Sherwin BB; Gelfand MM; Schucher R; Gabor J
Am J Obstet Gynecol; 1987 Feb; 156(2):414-9. PubMed ID: 3826177
[TBL] [Abstract][Full Text] [Related]
11. Effects of transdermal application of 7-oxo-DHEA on the levels of steroid hormones, gonadotropins and lipids in healthy men.
Sulcová J; Hill M; Masek Z; Ceska R; Novácek A; Hampl R; Stárka L
Physiol Res; 2001; 50(1):9-18. PubMed ID: 11300231
[TBL] [Abstract][Full Text] [Related]
12. Changes in lipids and lipoproteins with long-term estrogen deficiency and hormone replacement therapy.
Gambrell RD; Teran AZ
Am J Obstet Gynecol; 1991 Aug; 165(2):307-15; discussion 315-7. PubMed ID: 1872331
[TBL] [Abstract][Full Text] [Related]
13. Lipids and lipoproteins in women after oophorectomy and the response to oestrogen therapy.
Notelovitz M; Gudat JC; Ware MD; Dougherty MC
Br J Obstet Gynaecol; 1983 Feb; 90(2):171-7. PubMed ID: 6297536
[TBL] [Abstract][Full Text] [Related]
14. [Lipid profile modifications in post-menopausal women treated with testosterone gel].
Fernández-Carvajal J; Luz-Araujo H; Guerra-Velázquez M; Reyna-Villasmil E; Santos-Bolívar J; Torres-Cepeda D; Mejia-Montilla J; Reyna-Villasmil N
Endocrinol Nutr; 2012 Jan; 59(1):44-9. PubMed ID: 22115702
[TBL] [Abstract][Full Text] [Related]
15. Relationship of menopausal status and sex hormones to serum lipids and blood pressure.
Wu ZY; Wu XK; Zhang YW
Int J Epidemiol; 1990 Jun; 19(2):297-302. PubMed ID: 2376439
[TBL] [Abstract][Full Text] [Related]
16. The effect of oestradiol valerate therapy on coagulation factors and lipid and oestrogen levels in oöphorectomised women.
Saunders DM; Hunter JC; Shutt DA; O'Neill BJ
Aust N Z J Obstet Gynaecol; 1978 Aug; 18(3):198-201. PubMed ID: 283783
[TBL] [Abstract][Full Text] [Related]
17. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
18. The relation of endogenous sex steroid hormone concentrations to serum lipid and lipoprotein levels in postmenopausal women.
Cauley JA; Gutai JP; Kuller LH; Powell JG
Am J Epidemiol; 1990 Nov; 132(5):884-94. PubMed ID: 2239903
[TBL] [Abstract][Full Text] [Related]
19. Lipid and lipoprotein profile in menopausal transition. Effects of hormones, age and fat distribution.
Berg G; Mesch V; Boero L; Sayegh F; Prada M; Royer M; Muzzio ML; Schreier L; Siseles N; Benencia H
Horm Metab Res; 2004 Apr; 36(4):215-20. PubMed ID: 15114519
[TBL] [Abstract][Full Text] [Related]
20. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.
Bhathena RK; Anklesaria BS; Ganatra AM; Pinto R
Br J Clin Pharmacol; 1998 Feb; 45(2):170-2. PubMed ID: 9491833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
